Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events.

BMC Pharmacol Toxicol · 2024 · PMC11438280 · PMID 39334280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The incidence rate showed a decreasing trend quarter by quarter over time as follows: first quarter ( n = 284, 32.72%), second quarter ( n = 149, 17.17%), third quarter ( n = 105, 12.12%), and fourth quarter ( n = 66, 7.60%).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.